Bristol-Myers Squibb Co (LTS:0R1F)
$ 59.4 -0.61 (-1.02%) Market Cap: 119.70 Bil Enterprise Value: 163.01 Bil PE Ratio: 0 PB Ratio: 6.98 GF Score: 82/100

Bristol-Myers Squibb Co at Goldman Sachs Healthcare Conference Transcript

Jun 13, 2023 / 03:40PM GMT
Release Date Price: $64.6 (-0.46%)
Chris Shibutani
Goldman Sachs Group, Inc., Research Division - Research Analyst

Okay. Let's get underway. Good morning, everybody. Welcome to the second day of the 44th Annual Goldman Sachs Healthcare Conference. We are very pleased to have Bristol-Myers join us. Today from the team an opportunity to really focus in on some of the key business segments, we have Lynelle Hoch, Senior Vice President, Global Cell Therapy franchise live in in-person, you were impressive on Zoom at ASCO; and Roland Chen, who is an SVP in the cardiovascular development, also a very strategic pillar in terms of the portfolio for Bristol.

So what I'd like to do is make these conversations some connectivity that you're not just mouthpieces for Tim and Nina, but we know a little bit about who you are, where you came from. So a quick snap so on your professional journey that brings to bear so that we know how you think about stuff to communicate what's been in your dark and mysterious past? Lynelle you first.

Lynelle Hoch

okay. My dark and mysterious past. So Lynelle Hoch, I've been at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot